CIK 0001783328 · <br>Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825282075
- Phone
- 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Exit or restructuring costs · Delisting notice · Executive or director change · Regulation FD disclosure · Other events
- 8-K Event Agreement ended
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 1 of 5 · 89 filings